GAM
Gemmer Asset Management Portfolio holdings
AUM
$1.13B
1-Year Return
14.45%
This Quarter Return
-16.03%
1 Year Return
+14.45%
3 Year Return
+55.65%
5 Year Return
+77.08%
10 Year Return
+165.98%
AUM
$376M
AUM Growth
-$61.2M
(-14%)
Cap. Flow
+$16.1M
Cap. Flow
% of AUM
4.29%
Top 10 Holdings %
Top 10 Hldgs %
50.8%
Holding
1,561
New
191
Increased
344
Reduced
269
Closed
278
Top Buys
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$10.8M |
| 2 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.65M |
| 3 |
Essex Property Trust
ESS
|
+$2.21M |
| 4 |
Vanguard Small-Cap ETF
VB
|
+$2.01M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$1.66M |
Top Sells
| 1 |
Schwab International Equity ETF
SCHF
|
+$3.16M |
| 2 |
Schwab U.S Small- Cap ETF
SCHA
|
+$1.65M |
| 3 |
Schwab US Large-Cap Value ETF
SCHV
|
+$505K |
| 4 |
Visa
V
|
+$501K |
| 5 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$461K |
Sector Composition
| 1 | Technology | 14.86% |
| 2 | Financials | 5.46% |
| 3 | Industrials | 4.26% |
| 4 | Consumer Discretionary | 2.89% |
| 5 | Consumer Staples | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Columbia Banking Systems
COLB
$7.93B
| $5K | ﹤0.01% |
201
| – | – |
|
727
CRISPR Therapeutics
CRSP
$4.81B
| $5K | ﹤0.01% |
+125
| New | +$5K |
|
728
CSG Systems International
CSGS
$1.84B
| $5K | ﹤0.01% |
120
| – | – |
|
729
CubeSmart
CUBE
$9.28B
| $5K | ﹤0.01% |
+175
| New | +$5K |
|
730
HF Sinclair
DINO
$9.58B
| $5K | ﹤0.01% |
223
-127
| -36% | -$2.85K |
|
731
EnerSys
ENS
$3.94B
| $5K | ﹤0.01% |
92
+30
| +48% | +$1.63K |
|
732
Edgewell Personal Care
EPC
$996M
| $5K | ﹤0.01% |
150
+56
| +60% | +$1.87K |
|
733
TechnipFMC
FTI
$16.8B
| $5K | ﹤0.01% |
1,075
+540
| +101% | +$2.51K |
|
734
Haverty Furniture Companies
HVT
$378M
| $5K | ﹤0.01% |
434
+10
| +2% | +$115 |
|
735
Installed Building Products
IBP
$7.19B
| $5K | ﹤0.01% |
113
| – | – |
|
736
Iridium Communications
IRDM
$1.99B
| $5K | ﹤0.01% |
220
+73
| +50% | +$1.66K |
|
737
Kirby Corp
KEX
$4.86B
| $5K | ﹤0.01% |
106
-53
| -33% | -$2.5K |
|
738
Lumen
LUMN
$6.09B
| $5K | ﹤0.01% |
542
| – | – |
|
739
Manhattan Associates
MANH
$13B
| $5K | ﹤0.01% |
96
-70
| -42% | -$3.65K |
|
740
Pediatrix Medical
MD
$1.45B
| $5K | ﹤0.01% |
422
+292
| +225% | +$3.46K |
|
741
Mueller Industries
MLI
$10.8B
| $5K | ﹤0.01% |
456
-370
| -45% | -$4.06K |
|
742
Molina Healthcare
MOH
$9.61B
| $5K | ﹤0.01% |
37
+17
| +85% | +$2.3K |
|
743
Neogen
NEOG
$1.22B
| $5K | ﹤0.01% |
144
| – | – |
|
744
NeoGenomics
NEO
$983M
| $5K | ﹤0.01% |
166
+79
| +91% | +$2.38K |
|
745
National Grid
NGG
$69.8B
| $5K | ﹤0.01% |
98
+77
| +367% | +$3.93K |
|
746
Ingevity
NGVT
$2.09B
| $5K | ﹤0.01% |
146
+71
| +95% | +$2.43K |
|
747
NorthWestern Energy
NWE
$3.46B
| $5K | ﹤0.01% |
85
| – | – |
|
748
Onto Innovation
ONTO
$5.24B
| $5K | ﹤0.01% |
162
| – | – |
|
749
PetMed Express
PETS
$56.8M
| $5K | ﹤0.01% |
162
| – | – |
|
750
Polaris
PII
$3.28B
| $5K | ﹤0.01% |
96
+34
| +55% | +$1.77K |
|